Medication education task force providing valuable resources to CPNP members

Werremeyer, Amy; Saldaña, Shannon N.; Goldstone, Lisa; Justino, J. Daniel

doi:10.9740/mhc.n140747

Cited by 4 publications

(7 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[14][15][16] This represents a paucity in the literature, as a survey in 2012 found 87% of 47 psychiatric pharmacist respondents to currently be providing PMEGs. 17 Previous reports suggest improvements in patients understanding and feelings toward their medications following a twicemonthly PMEG focusing on various pharmacologic drug classes, 8 but no changes in medication knowledge or burden of adverse events after a twice-weekly PMEG focusing on adverse effects and medication adherence. 9 It was also found that medication attitudes and knowledge could be captured using questionnaires, 10 and focused PMEGs may increase acceptance of coronavirus disease 2019 (COVID-19) vaccination.…”

Section: Introductionmentioning

confidence: 98%

Inpatient psychiatry patient medication education groups: A retrospective observational case series evaluating education provided on prescribed psychiatric medications at discharge and documentation practices

McGrane,

Nuebel,

Shooshtari

2023

J Am Coll Clin Pharm

View full text Add to dashboard Cite

IntroductionPatient medication education groups (PMEGs) during inpatient psychiatric hospitalizations have occurred for over 40 years. It is unknown to what degree patients are educated on their prescribed medications following PMEGs, or, pharmacist PMEG documentation practices.ObjectivesThe primary objective was to determine the percentage of patients educated on their newly prescribed or continued psychiatric medications at hospital discharge during daily pharmacy‐delivered education sessions at an inpatient psychiatric hospital.MethodsThis single‐center, six‐month, retrospective observational case series of PMEGs and individual education occurred during acute inpatient psychiatric hospitalization. Educational content was adapted by the board‐certified psychiatric pharmacist (BCPP) to emphasize medications that attendees wished to discuss. Data collection included demographics, medications prescribed at discharge, educational content provided, and documentation by pharmacy staff regarding attendees' behaviors and shared medication experiences. The chi‐square test was used to determine differences in percentages of patients educated on psychiatric medication classes.ResultsA total of 87 PMEGs and 90 individual patient education were performed, reaching 230 unique patients. The average patient attended two PMEGs. Patients prescribed the following scheduled medication classes at discharge were educated on them: antipsychotics (76.3%), antidepressants (67.3%), antiepileptic drugs (66.7%), substance use disorder medications (63.6%), lithium (60%), and non‐antidepressant anti‐anxiety medications (58.6%). Education was provided more frequently on newly prescribed medication classes (79%) compared to continued medication classes at discharge (58.3%) (p = 0.00001). Individual patient interactions during educational sessions documented behavioral or psychiatric symptoms (68%), patient‐sharing experience with medications (39%), medication‐related concerns (28%), medication efficacy comments (18%), and interest in pharmacotherapy modification (14%).ConclusionNearly 80% of patients who attended PMEG or met individually with the BCPP were educated on newly prescribed scheduled psychiatric medications. Additional research is needed to determine patient preference of how education is delivered, and how PMEGs impact pharmacist interventions, medication adherence, and hospital readmission rates.

show abstract

Section: Introductionmentioning

confidence: 98%

Inpatient psychiatry patient medication education groups: A retrospective observational case series evaluating education provided on prescribed psychiatric medications at discharge and documentation practices

McGrane,

Nuebel,

Shooshtari

2023

J Am Coll Clin Pharm

View full text Add to dashboard Cite

show abstract

“…A recent publication has suggested that delivery of education by a pharmacist to a group of patients may be more efficient and potentially just as effective as that delivered to patients individually . The patient medication education group (PMEG) is an intervention in which education is provided to two or more patients about medications or issues related to medication use, with content tailored to the needs of patients in each group . However, early research into PMEGs has shown conflicting results.…”

Section: Introductionmentioning

confidence: 99%

Pharmacist‐led medication education groups on an inpatient psychiatric unit—Impact on readmissions and emergency department visits

Werremeyer

Orr

2018

J Am Coll Clin Pharm

Self Cite

View full text Add to dashboard Cite

Introduction The optimal mechanism for delivery of medication education by pharmacists in the inpatient setting is unclear. Objectives To evaluate the impact of pharmacist‐led patient medication education groups (PMEGs) conducted in an inpatient psychiatry unit and to further delineate factors associated with psychiatric rehospitalization. Methods A retrospective cohort study of 593 individual admissions in which PMEG attenders (n = 298) participated in one or more medication education sessions. The pharmacist leader served as moderator and utilized a motivational interviewing approach. PMEG nonattenders (n = 285) received usual care. Binomial logistic analyses and multiple linear regression analysis were used to identify factors associated with 90‐day and 12‐month psychiatric readmission, 12‐month medical hospitalization, 12‐month emergency department (ED) visits for psychiatric reasons, and time to psychiatric readmission. Results After controlling for multiple factors, attendance at a single PMEG session was not associated with a reduction in any of the above outcomes. Attendance at two or more PMEG sessions was associated with a reduction in ED visits for psychiatric reasons (P = 0.0433). For each additional diagnosis, odds of a 90‐day psychiatric readmission rose by a factor of 1.4. Patients prescribed antipsychotic or hypnotic medications were 2.4 and 2.5 times, respectively, more likely to experience 90‐day psychiatric readmission. PMEG attendance did not lower the readmission risk for these high risk patients. Conclusion A single PMEG intervention for psychiatric inpatients was not effective in reducing psychiatric readmission, but patients who participated in two or more PMEGs had fewer ED visits than those who attended only one PMEG. Additional research is needed regarding PMEG impacts on medication knowledge and attitude, as well as other potential reasons for psychiatric health care utilization.

show abstract

“…20 Interestingly, 40% of the survey respondents indicated that they had been asked to begin a new PMEG service in their institution but had not yet initiated it; the barriers to implementing the requested services were not investigated. 31 The psychiatric and neurologic pharmacist survey results suggest that institutions serving the psychiatric population recognize the value of the PMEG.…”

mentioning

confidence: 98%

“…Results obtained from a voluntary survey of 72 psychiatric and neurologic pharmacists (65% response rate) revealed that 41 (87%) of 47 respondents provided PMEGs. 31 The pharmacists indicated that they incorporated a number of strategies in these groups, including the provision of written material, and that the groups were provided to patients in a variety of healthcare settings. Further, over 50% of respondents reported that nonpharmacists provided medication education to groups of patients in their institutions, similar to the percentage found in a 2009 national survey, which revealed that 89% of one-on-one medication education in hospitals was provided by nursing staff.…”

mentioning

confidence: 99%